Violation Tracker Parent Company Summary

Parent Company Name: 
Novo Holdings A/S
Ownership Structure: 
privately held
Headquartered in: 
Denmark
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$104,550,956
Number of records: 
12
Top 5 Offense Groups (Groups Defined)Penalty TotalNumber of Records
government-contracting-related offenses$60,375,0003
healthcare-related offenses$26,100,0003
competition-related offenses$18,030,1492
environment-related offenses$40,1973
safety-related offenses$5,6101
Top 5 Primary Offense TypesPenalty TotalNumber of Records
False Claims Act and related$60,375,0003
off-label or unapproved promotion of medical products$26,100,0003
Foreign Corrupt Practices Act$9,030,1491
kickbacks and bribery$9,000,0001
environmental violation$40,1973
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Associated Names: 

NOVO NORDISK; NOVO NORDISK A / S; NOVO NORDISK BIOCHEM NA; NOVOZYMES BIOLOGICALS INC

Links: 

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML
Company Primary Offense Type Year Agency Penalty Amountsort icon
Novo Nordisk Inc. False Claims Act and related 2017 DOJ_CIVIL $58,650,000
Novo Nordisk Inc. off-label or unapproved promotion of medical products 2011 FDA $25,000,000
Novo Nordisk A/S Foreign Corrupt Practices Act 2009 SEC $9,030,149
Novo Nordisk A/S kickbacks and bribery 2009 DOJ_CRIMINAL $9,000,000
Novo Nordisk Inc. off-label or unapproved promotion of medical products 2011 MULTI-AG (*) $3,574,209
Novo Nordisk Inc. False Claims Act and related 2017 MULTI-AG (*) $3,320,963
Novo Nordisk Inc. False Claims Act and related 2011 USAO $1,725,000
Novo Nordisk Inc. off-label or unapproved promotion of medical products 2017 CA-INS $1,100,000
NOVOZYMES BIOLOGICALS, INC environmental violation 2009 EPA $26,797
NOVOZYMES BIOLOGICALS, INC. environmental violation 2016 EPA $8,400
NOVOZYMES BIOLOGICALS, INC. workplace safety or health violation 2003 OSHA $5,610
NOVO NORDISK BIOCHEM, N.A., INC. environmental violation 2000 EPA $5,000
Download results as CSV or XML